These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 18954743)

  • 21. [Progress in the treatment of non-Hodgkin's lymphomas].
    Varga F; Demeter J
    Magy Onkol; 2001; 45(1):45-50. PubMed ID: 12050728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 19-1992. A 56-year-old man with Waldenström's macroglobulinemia and cutaneous and oral vesicles.
    N Engl J Med; 1992 May; 326(19):1276-84. PubMed ID: 1560805
    [No Abstract]   [Full Text] [Related]  

  • 23. The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing.
    Swerdlow SH; Kuzu I; Dogan A; Dirnhofer S; Chan JK; Sander B; Ott G; Xerri L; Quintanilla-Martinez L; Campo E
    Virchows Arch; 2016 Mar; 468(3):259-75. PubMed ID: 26454445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Research progress on epigenetics of small B-cell lymphoma.
    Ruan X; Zhang R; Zhu H; Ye C; Wang Z; Dong E; Li R; Cheng Z; Peng H
    Clin Transl Oncol; 2022 Aug; 24(8):1501-1514. PubMed ID: 35334078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Allogeneic haematopoietic cell transplantation for indolent lymphomas: Guidelines from the Francophone Society Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Gauthier J; Chantepie S; Bouabdallah K; Jost E; Nguyen S; Gac AC; Damaj G; Duléry R; Michallet M; Delage J; Lewalle P; Morschhauser F; Salles G; Yakoub-Agha I; Cornillon J
    Bull Cancer; 2017 Dec; 104(12S):S121-S130. PubMed ID: 29173973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Waldenström's macroglobulinemia and large B-cell central nervous system lymphoma: a case report.
    Langevin JP; Bergsneider M; Yashar P; Makary RF
    Surg Neurol; 2008 Apr; 69(4):407-10. PubMed ID: 18262236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Waldenström's macroglobulinemia: prognostic factors and recent therapeutic advances.
    Leblond V; Tournilhac O; Morel P
    Clin Exp Med; 2004 Apr; 3(4):187-98. PubMed ID: 15103509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous stem cell transplantation as part of first-line treatment of Waldenström's macroglobulinemia.
    Dreger P; Schmitz N
    Biol Blood Marrow Transplant; 2007 May; 13(5):623-4. PubMed ID: 17448924
    [No Abstract]   [Full Text] [Related]  

  • 29. [Salient clinical features of lymphoma and related lymphoproliferative disorders].
    Fey MF
    Ther Umsch; 2010 Oct; 67(10):491-5. PubMed ID: 20886453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is lymphoplasmacytic lymphoma/immunocytoma a distinct entity? A clinicopathologic study of 20 cases.
    Andriko JA; Swerdlow SH; Aguilera NI; Abbondanzo SL
    Am J Surg Pathol; 2001 Jun; 25(6):742-51. PubMed ID: 11395551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma.
    Juárez-Salcedo LM; Castillo JJ
    Hematol Oncol Clin North Am; 2019 Aug; 33(4):639-656. PubMed ID: 31229160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities.
    Braggio E; Dogan A; Keats JJ; Chng WJ; Huang G; Matthews JM; Maurer MJ; Law ME; Bosler DS; Barrett M; Lossos IS; Witzig TE; Fonseca R
    Mod Pathol; 2012 May; 25(5):651-60. PubMed ID: 22301699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autopsy case of lymphoplasmacytic lymphoma with a large submucosal tumor in the stomach.
    Okada Y; Mori H; Maeda T; Ito Y; Hasegawa M; Kageyama T
    Pathol Int; 2001 Oct; 51(10):802-6. PubMed ID: 11881734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Waldenström macroglobulinemia: a review of therapy.
    Gertz MA
    Am J Hematol; 2005 Jun; 79(2):147-57. PubMed ID: 15929102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Indolent lymphomas: classification, clinical presentation and treatment]].
    Zenhäusern R
    Praxis (Bern 1994); 2013 Mar; 102(7):399-406. PubMed ID: 23531907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Waldenström's macroglobulinemia with an uncommon presentation].
    Trueba F; Maslin J; Coutant G; Guymar S; Vigezzi JF; Desangles F; Nizou JY; Nicand E
    Ann Biol Clin (Paris); 2006; 64(1):73-5. PubMed ID: 16420993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune thrombocytopenia in non-Hodgkin's lymphomas.
    Hauswirth AW; Skrabs C; Schützinger C; Raderer M; Chott A; Valent P; Lechner K; Jäger U
    Haematologica; 2008 Mar; 93(3):447-50. PubMed ID: 18287133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathologic subtypes of indolent lymphomas: caricatures of the mature B-cell system.
    Jaffe ES; Raffeld M; Medeiros LJ
    Semin Oncol; 1993 Oct; 20(5 Suppl 5):3-30. PubMed ID: 8211205
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of stem cell transplantation in Waldenstrom's macroglobulinemia.
    Chakraborty R; Muchtar E; Gertz MA
    Best Pract Res Clin Haematol; 2016 Jun; 29(2):229-240. PubMed ID: 27825469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current therapeutic options for subgroups of chronic lymphocytic leukemia. Planning risk-adapted treatment according to recognized prognostic factors.
    Polliack A
    Haematologica; 2003 Jul; 88(7):726-9. PubMed ID: 12857547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.